Mat-A-Cell manufactures and sells biocompatible iSECnM (Inorganic Sculptured ExtraCellular NanoMatrices) for differentiating neural stem cells to neurons, applied to cell therapies for neurodegenerative diseases with minimized risk of induced cancer. The market for the healthcare applications of our invention is worth millions of US dollars per year. The target customers are research institutions and hospitals.